✦ LIBER ✦

How have outcomes for patients with follicular lymphoma changed with the addition of monoclonal antibodies?

✍ Scribed by Illidge, Tim; Chan, Clara

Book ID: 120552322
Publisher: Informa plc
Year: 2008
Tongue: English
Weight: 169 KB
Volume: 49
Category: Article
ISSN: 1042-8194
DOI: 10.1080/10428190802090805

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Monoclonal antibodies combined to chemot

Monoclonal antibodies combined to chemotherapy for the treatment of patients with lymphoma

✍ Bertrand Coiffier 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Initial Trials of Anti-CD80 Monoclonal A

Initial Trials of Anti-CD80 Monoclonal Antibody (Galiximab) Therapy for Patients with Relapsed or Refractory Follicular Lymphoma

✍ Younes, Anas; Hariharan, Kandasamy; Allen, Roberta S.; Leigh, Bryan R. 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 120 KB

Prognostic factors for the clinical outc

Prognostic factors for the clinical outcome of patients with follicular lymphoma following high-dose therapy and peripheral blood stem cell transplantation (PBSCT)

✍ Voso, M T; Martin, S; Hohaus, S; Abdallah, A; Schlenk, R F; Ho, A D; Haas, R 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 86 KB

Promising biomarkers for predicting the

Promising biomarkers for predicting the outcomes of patients with KRAS wild-type metastatic colorectal cancer treated with anti-epidermal growth factor receptor monoclonal antibodies: A systematic review with meta-analysis

✍ Yang, Zu-Yao; Wu, Xin-Yin; Huang, Ya-Fang; Di, Meng-Yang; Zheng, Da-Yong; Chen, 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 French ⚖ 937 KB

Does the Addition of Involved Field Radi

Does the Addition of Involved Field Radiotherapy to High-dose Chemotherapy and Stem Cell Transplantation Improve Outcomes for Patients with Relapsed/Refractory Hodgkin Lymphoma?

✍ Kahn, S.T.; Flowers, C.; Xu, Z.; Esiashvili, N. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 41 KB

MP12-01 INTRAOPERATIVE ADJUSTMENT OF TRE

MP12-01 INTRAOPERATIVE ADJUSTMENT OF TREATMENT PLAN AND TISSUE CHANGE MONITORING OF THE PROSTATE HAVE POTENTIAL FOR IMPROVING ONCOLOGICAL OUTCOMES IN THE PATIENTS WITH LOCALIZED PROSTATE CANCER TREATED WITH ULTRASOUND-GUIDED HIGH INTENSITY FOCUSED ULTRASOUND

✍ Shoji, Sunao; Tomonaga, Tetsuro; Kim, Hakushi; Nakano, Mayura; Nagata, Yoshihiro 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 196 KB